Healthcare Chatbots Market Research 2019

1. Healthcare Chatbots Market Application Opportunity Wins Big with Boosted at a Growth Rate of 21.10% By Rise in Demand for Cloud-Based Models and High Surge of Internet Use Market Research Future (MRFR) provides insight into the healthcare chatbots market in its latest report, expecting it to attain the valuation of 316.85 million by 2023. It is projected to rise at a growth rate of 21.10% during the forecast period (2018-2023). Market Overview The market expects excellent growth in the near future with the promotion as well as emergence of cloud-based models. Cloud-based models offer ubiquitous, convenient, and on-demand network access to a shared group of configurable computing resources for quickly releasing and supplying service provider interaction. Basically, there are three primary types of cloud computing models, namely software, infrastructure, as well as platform as a service. With the increasing implementation of such cloud-computing model systems, the worldwide market for healthcare chatbots is expected to rise significantly in the coming years. Prominent factors boosting the healthcare chatbots market include the need for virtual health assistance. This factor works on the back of rising modernization and human dependency on technology. Other than that, social-media platforms offering chatbots also help elevate the adoption of healthcare chatbots today. Request for FREE Sample Copy@ https://www.marketresearchfuture.com/sample_request/6476 Prominent Companies Numerous companies are undertaking initiatives for boosting the use of healthcare chatbots aided by advertising and marketing techniques, particularly with the use of online platforms. The prominent companies in the worldwide healthcare chatbots market includes, • • • • • • • • • Sensely Inc. (U.S.) COM Inc. (U.S.) Woebot Labs Inc. (U.S.) PACT Care BV (The Netherlands) MD (U.K.) Buoy Health Inc. (U.S.) HealthTap Inc. (U.S.) Ada Health GmbH (Germany) Babylon Health (U.K.) Market Research Future

2. • • Infermedica (Poland) and others. Market Segmentation The worldwide market for healthcare chatbots has been segmented with respect to component, deployment, application, and end-user. In terms of component, the market caters to software and services. The software covered close to 82.1% of the total market in 2017, whereas services accumulated the share of around 17.9%. The software segment can expect to achieve 21.40% CAGR during the review period to touch the valuation of roughly USD 264.07 million by 2023. The software’s ability to provide unbiased and relevant data backed by natural language processing (NLP) and artificial intelligence (AI) is likely to maintain its segmental dominance. Furthermore, services segment is poised to generate about USD 52.77 million by 2023. Deployment-wise, on-premise and cloud-based segments have been covered by the report. Among these, the on-premise segment’s coverage in the healthcare chatbots market was about 64.6% in 2017, while the cloud-based segment managed to retain 35.4%. On-premise offers exceptional qualities like efficiency and customization to provide personalized care services. On top of that, the cheap operational expenditure makes this type of deployment more profitable for end-users. As a result, the segment can expect to reach at the valuation of USD 203.36 million by 2023. Additionally, the cloud-based deployment could expect to be worth USD 113.48 million by 2023 on account of quicker retrieval of clinical and non-clinical data records as well as their storage. With context to application, the segments are medication assistance and appointment scheduling & medical guidance. The larger portion of the market is under the medication assistance segment which was around 85% in 2017, while the appointment scheduling & medical guidance segment could obtain around 15% of the total market. The former is expected to double its value from USD 85.43 million in 2017 to USD 268.60 million by the end of the review period. The main reason responsible for this is the rising use of healthcare chatbots to handle patient engagement along with organizes healthcare records. While the latter will be touching the valuation of USD 48.25 million by 2023 as a result of the increasing use of virtual assistants to reduce response times. The end-users in the market are patients, healthcare providers, insurance companies and others. The patients segment accounted for 58.4% share in 2017, trailed by healthcare providers that covered about 28.7% and the insurance companies obtained roughly 8.5% of the total market. Patients have been identified as the biggest end-user owing to the demand for real-time diagnosis. Besides, chatbots help remind patients to take their medicines on time and also report if the dose is missed which ensures the health of patients. The report also reveals that the healthcare providers segment can demonstrate 21.34% CAGR to reach USD 92.11 million by 2023. Market Research Future

3. Get Full Detailed Copy of This Report@ https://www.marketresearchfuture.com/reports/healthcare-chatbots-market-6476 Regional Insight The main markets for healthcare chatbots are Europe, Asia Pacific (APAC), the Middle East & Africa (MEA) and the Americas. Europe was the reigning regional market in 2017 with around 40.3% share, whereas North America accounted for 36.4%, APAC seized 19%, and MEA could obtained almost 4.3% of the worldwide market. Europe healthcare chatbots market can expect to touch the valuation of USD 129.36 million by 2023. The market growth gets major support from the rising prevalence of chronic diseases and the steady adoption of bots for mitigating the burden of hospitals in the region. On top of that, massive investments for expediting the advancement of artificial intelligence are perceived to benefit the market in the ensuing years. The healthcare chatbots market in the Americas is predicted to come to the valuation of USD 117.18 million by 2023 at a striking CAGR of 21.46%. Huge funding for adoption of chatbots and AI to improve the regional medical infrastructure is believed to favor the market in the years to come. APAC is set to display CAGR of 21.16% during the conjectured time frame to arrive at the valuation of USD 60.48 million by 2023. The market growth will be evident backed by the rising initiatives by governments for boosting the development of AI. Also, numerous drug manufactures are striving to come up with their own chatbots to handle multiple queries, which can be exemplified by Lupin’s newly launched ‘ANYA’. Industry Update June 2019 Youper, an app featuring mental health chatbot has obtained USD 3 million of funding from Goodwater Capital. These funds will be used to develop Youper’s artificial intelligence-based capabilities, in addition to expanding its user base. Ask for an Exclusive Discount@ https://www.marketresearchfuture.com/check- discount/6476 Intended Audience • • • • • Hospitals & Clinics Healthcare IT Solution Providers Healthcare IT Vendors Healthcare IT Service Providers Diagnostic Laboratories Market Research Future

4. • • • • Healthcare Payers Government Institutes Market Research and Consulting Firms Venture Capitalists and Investors About Market Research Future: we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members. Contact: Market Research Future +1 646 845 9312 Email: sales@marketresearchfuture.com Market Research Future